PetMed Express logo
PetMed Express
PETS | NASDAQ
Chart Builder DCF Calculator
$0.90
-$0.04 (-4.28%)
At close: Nov 16, 2026, 4:00 PM ET
$0.90
$0.00 (-0.26%)
After-hours: Nov 16, 2026, 7:30 PM ET

PetMed Express Company Profile

Company profile explained

Company Profile

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

Key Executives

Name Position
Jeffrey Allen Willard Chief Executive Officer, Pres & Director
Andrew Parry Chief Technology Officer
Caroline Conegliano Chief Growth Officer
Doug Krulik Chief Accounting Officer, Principal Acc. Off., Interim Principal Financial Officer & Treasurer
Jacqueline Smith Vice President of People
Leslie C. G. Campbell Strategic Advisor
Robert Lawsky Corporate Secretary & General Counsel
Wendy Zalai Corporate Controller & Corporate Secretary

Latest SEC Filings

Date Type Title
Sep 29, 2026 4 Filing
Sep 29, 2026 3 Filing
Sep 28, 2026 S-8 Filing
Sep 28, 2026 S-8 Filing
Sep 28, 2026 8-K Current Report
Sep 21, 2026 4 Filing
Sep 21, 2026 3 Filing
Sep 21, 2026 8-K Current Report
Sep 17, 2026 8-K Current Report
Aug 13, 2026 4 Filing
View All SEC Filings ➞
PetMed Express
PetMed Express logo
Country United States
IPO Date Apr 26, 1999
Industry Specialty Retail
Sector Consumer Cyclical
Employees 189
CEO Jeffrey Allen Willard

Contact Details

420 South Congress Avenue Delray Beach, Florida 33445 United States

Stock Details

Ticker Symbol PETS
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001040130
CUSIP Number 716382106
ISIN Number US7163821066
SIC Code 5912

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.